• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Radiopharmaceuticals - Global Strategic Business Report Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • ID: 835008
  • March 2015
  • Region: Global
  • 274 Pages
  • Global Industry Analysts, Inc
New Therapeutic Radiopharmaceuticals to Drive Global Market

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 57 companies including many key and niche players such as:

- Actinium Pharmaceuticals Inc.
- Advanced Medical Isotope Corporation
- Alliance Medical
- Alseres Pharmaceuticals, Inc.
- Avid Radiopharmaceuticals

Note: Product cover images may vary from those shown
New Therapeutic Radiopharmaceuticals to Drive Global Market

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions And Scope Of Study
A. Diagnostic Radiopharmaceuticals
B. Therapeutic Radiopharmaceuticals

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

A Quick Primer
Market Drivers
Growing Acceptance in Cancer Treatment
Increasing Acceptance of Disease-Targeted Treatment
Growing Emphasis of Accurate Diagnosis
Expanding Molecular Imaging Applications
Market Restraints
Stringent Regulatory Guidelines
Global Supply Shortages
Price Sensitivity & Competition from Alternatives
Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy
Unfounded Fears of Radiation Exposure Hinder Growth
Bottlenecks in Developing Markets
Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
Market Scenario
Recession: A Period of Global Decline
The Road to Recovery
Impact of Healthcare Budget Cuts in Developed Economies: A Review
Current & Future Analysis
Diagnostic Radiopharmaceuticals: The Dominant Segment
PET: A Prime Growth Driver
Introduction of SPECT/CT & PET/CT Boosts Growth
Select PET and SPECT Radioisotopes Used in Nuclear Medicine
Select Cardiology and Oncology Radiopharmaceuticals
New Therapeutic Radiopharmaceuticals to Drive Global Market
Rise in Cancer Incidences & Access to Modern Therapeutics Foster Growth
World Cancer Statistics
Incidence and Mortality Data
Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 2: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 3: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers
Competition

2. MARKET TRENDS & ISSUES

Companies Explore New Frontiers of Therapeutic Radiopharmaceuticals
Targeted Radionuclide Therapy: Gains Ground in Cancer Treatment
Battling Alzheimer’s Disease
A Powerful Market Force
List of FDA Approved Alzheimer's Diagnostic Imaging Agents
Hypoxia Imaging Presents Opportunities for PET
Rise in Investments and International Collaborations for Drug Development
Intra-operative Lymphatic Mapping (ILM): Creates New Opportunities for Radiopharmaceuticals in Cancer Detection
Cardiology: An Important Sector for Radiopharmaceuticals
PET Application in Drug Development to Expand Opportunities
Emergence of Radioisotope Based Personalized Therapy Bodes Well for the Market

3. RADIO ISOTOPES MO-99/TC 99 SUPPLIES A REVIEW

Reactors Producing Cobalt 60 & Molybdenum 99
Table 4: Global Projected Demand for Mo-99 in Emerging and Mature Markets for the Years 2020 and 2030 (includes corresponding Graph/Chart)
Table 5: Worldwide Market Demand for Mo-99 by Region (2013): Percentage Share Breakdown of Demand for Australia, Canada, China, EU, Japan, Russia, US, and Others (includes corresponding Graph/Chart)
Table 6: Worldwide Mo-99 Production by Region (2013): Percentage Share Breakdown of Annual Production for Australia, Canada, EU, Russia, South Africa, and Others (includes corresponding Graph/Chart)
Table 7: Global Mo-99 Reactors by Production Capacity (2013): Percentage Share Breakdown of Annual Production Capacity for BR2/Belgium, HFR/ Netherlands, LVR-15/Czech Republic, MARIA/Poland, NRU/Canada, OPAL/Australia, OSIRIS/France, RA-3/Argentina, and SAFARI/South Africa (includes corresponding Graph/Chart)
Table 8: Global Tc-99m Processors By Production Capacity (2013): Percentage Share Breakdown Of Annual Production Capacity for AECL/Canada, ANSTO/Australia, CNEA/Argentina, IRE/Belgium, Mallinckrodt/Netherlands, and NTP/South Africa (includes corresponding Graph/Chart)
Supply Shortages: A Cause of Concern
Combating the Anticipated Shortage of RadioIsotopes
Radiopharmacy: A Key Link in the Distribution Chain
Table 9: US Radiopharmacies Market (2014): Percentage Share Breakdown of SPECT Doses Sold by Company

4. THERAPEUTIC RADIOPHARMACEUTICAL PRODUCTS UNDER DEVELOPMENT

Primer
Lutathera for Neuroendocrine Cancer
Actimab for Leukemia and Blood Borne Cancers
Lead-212 Alpha Therapy for Metastasized Abdominal Cancers
Lu-177-J591 PSMA Antibody for Prostate Cancer
Indium-111-Pentetreotide for Neuroendocrine Tumors
Yttrium-90 Clivatuzumab for Pancreatic Cancer
Phospholid Ether Tumor Targeting

5. IMAGING AGENTS AN OVERVIEW

A Quick Primer
Growth Drivers
Market Restraints
Significance of Technological Advancements
X-Ray Contrast Media: Giving Way to Emerging Modalities
Medical Reimbursement: A Critical Factor
Market Structure
Select Players by Segment

6. NUCLEAR MEDICINE AN OVERVIEW

Nuclear Medicine
An Introduction
Growth Drivers in a Nutshell
Market Shifts to Hybrid Imaging

7. PRODUCT OVERVIEW

Radiopharmaceuticals: A Definition
Mechanism of Action
Application of Radiopharmaceuticals
Radioactive Tracers for Diagnostic Imaging
Therapeutics
Research
Sterilization
Classification of Radiopharmaceuticals
Diagnostic Radiopharmaceuticals
Commonly Used Diagnostic Radiopharmaceutical Agents
Major Isotopes and their Diagnostic Applications
Advantages
Classification
Cardiology Diagnostics
Non-cardiology Diagnostics
Molecular Imaging Modalities in Radiopharmaceutical Diagnostics
Planar Imaging
Positron Emission Tomography (PET)
Advantages
Applications of PET
Commonly used Radioisotopes in PET Scans
Major PET Isotopes and their Applications
Single Photon Emission Computed Tomography (SPECT)
Applications of SPECT
Commonly used Radioisotopes in SPECT Scans
Therapeutic Radiopharmaceuticals
Characteristics of Therapeutic Radiopharmaceuticals
Commonly used Therapeutic Agents
Major Isotopes and their Therapeutic Applications
Radiopharmaceuticals for Thyroid Therapy
Radiopharmaceuticals for Cancer Therapy
Radiopharmaceuticals for Neuroendocrine Tumors
Radiopharmaceuticals for Radiosynoviorthesis Therapy
Radiopharmaceuticals for Bone Pain Palliation Therapy

8. PRODUCT INNOVATIONS/INTRODUCTIONS

Navidea Biopharmaceuticals Launches Lymphoseek
Positron Launches Advanced PosiRx Pharmacy Automation Systems
BARC Launches Indigenous Radiopharmaceuticals-Powered Scans
Rapidscan Pharma Solutions EU and GE Healthcare Unveil Rapiscan®

9. RECENT INDUSTRY ACTIVITY

Fujifilm Enters the Radiopharmaceutical Market
AAA Acquires GE’s Italian Radiopharmaceutical Business
Triad Isotopes Awarded HealthTrust Contract
Positron Enters Licensing Agreement with Russian INR
Siemens to Offer PET Pharmaceutical Services in US Market
Zevacor Molecular Acquires Pioneer Radiopharmacy
Navidea Enters Agreement with Siemens’ PETNET Solutions
Positron Enters Supply Agreement with iThemba Labs
Covidien Spins Off Pharmaceuticals Business
Navidea Enters Agreement with Nordion
Lantheus Enters into Agreement with Fujifilm
Advanced Accelerator Applications Expands Radiopharmaceutical Manufacturing Network
Advanced Accelerator Applications Inks Partnership Agreement with Uwrc Spoka Z Ograniczon Odpowiedzialno Ci
Eli Lilly to Purchase Two Radiopharmaceutical Imaging Agents from Siemens
UPPI Inks Contract with Novation
Dalton Inks Manufacturing Partnership with Clarity Pharmaceuticals
Lantheus Medical Imaging Extends Agreement with Nordion
Lantheus Medical Imaging and Jubilant HollisterStier Enter into Agreement
NCM Reveals New Advanced PET Radiopharmaceutical Manufacturing Center
Turkey Inaugurates First Particle Accelerator
SK Capital and IBA Sign Agreement to Setup IBA Molecular Imaging

10. FOCUS ON SELECT PLAYERS

Actinium Pharmaceuticals Inc (US)
Advanced Medical Isotope Corporation (US)
Alliance Medical (UK)
Alseres Pharmaceuticals, Inc (US)
Avid Radiopharmaceuticals (US)
Bayer HealthCare Medical Care (US)
Bracco Diagnostics, Inc. (US)
Cardinal Health, Inc (US)
GE Healthcare (UK)
Ion Beam Applications S.A (Belgium)
Immunomedics, Inc. (US)
Jubilant Pharma (India)
Lantheus Medical Imaging Inc (US)
Mallinckrodt Pharmaceuticals (Ireland)
Medi-Radiopharma Ltd (Hungary)
Nordion, Inc. (Canada)
Peregrine Pharmaceuticals, Inc. (US)
PETNET Solutions Inc (US)
Positron Corporation (US)
Singapore Radiopharmaceuticals Pte Ltd (Singapore)
Triad Isotopes, Inc. (US)

11. GLOBAL MARKET PERSPECTIVE

Table 10: World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 12: World 15-Year Perspective for Radiopharmaceuticals by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 15: World 15-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 16: World Recent Past, Current & Future Analysis for Therapeutic Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 17: World Historic Review for Therapeutic Radiopharmaceuticals by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 18: World 15-Year Perspective for Therapeutic Radiopharmaceuticals by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Outlook
Industry Structure
Production Scenario
Dependence on Imports
Regulatory Scenario
Thorny Regulations Dampen New Product Development
Market Overview
Expanding Diagnostic Applications Stimulate Future Growth
Cardiovascular Imaging to Lead Volume Growth
Table 19: The US Diagnostic Radiopharmaceutical Agents Market (2014): Percentage Share Breakdown of Procedure Volume by Imaging Procedure
SPECT and PET (includes corresponding Graph/Chart)
Table 20: US Market for Diagnostic Radiopharmaceuticals Agents (2014): Percentage Share Breakdown of Value Sales for Cardiology and Non-Cardiology Applications (includes corresponding Graph/Chart)
New Neurology Agents to Boost Growth
List of FDA Approved Alzheimer's Diagnostic Imaging Agents
Alzheimer’s Stats
Table 21: Alzheimer’s Prevalence in the US: As a Percentage of Population by Age-Group (includes corresponding Graph/Chart)
Table 22: US Market for Non-Cardiology Diagnostic Radiopharmaceuticals Agents (2014): Percentage Share Breakdown of Value Sales for Oncology and Non-Oncology Applications (includes corresponding Graph/Chart)
Adoption of SPECT/CT Scanners on Rise
Radiopharmaceuticals in PET Imaging
Prospects
Focused R&D Efforts to Fuel Therapeutic Radiopharmaceuticals Market
Market Share Statistics
Table 23: US Market for Diagnostic Radiopharmaceuticals Agents (2014): Percentage Market Share Breakdown for Leading Players (includes corresponding Graph/Chart)
Table 24: US Market for Therapeutic Radiopharmaceuticals (2014): Percentage Share Breakdown of Value Sales by Key Radiotherapeutics
Bone Palliation, Non-Hodgkin's Lymphoma, Hyperthyroidism/Thyroid Cancer and Others (includes corresponding Graph/Chart)
Table 25: US Market for Therapeutic Radiopharmaceutical Agents (2014E): Percentage Market Share Breakdown of Leading Players (includes corresponding Graph/Chart)
Rising Incidence of Cancer
A Major Growth Driver
Table 26: US Cancer Incidence (2014): No. of Reported New Cases by Gender (includes corresponding Graph/Chart)
Table 27: US Incidence of Common Cancers (2014): Number of New Cases Reported by Affected Site (includes corresponding Graph/Chart)
Overview of Medicare Reimbursements
Medicare Payment Settings for Radiopharmaceuticals
Table 28: Select 2015 Medicare Payment for Hospital Outpatients and Physician Office
Contrast Agents and Diagnostic Radiopharmaceuticals Bundled As Supplies
Table 29: Packaged components of SPECT Multiple Myocardial Perfusion Procedure
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 30: US Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 31: US Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 32: US 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Outlook
Canadian Scientists Gear up to find Remedy for Mo-99 Supply Shortages
An Overview of Medical Imaging Market
Regulatory and Legal Restrictions
Select Players
B.Market Analytics
Table 33: Canadian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34: Canadian Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 35: Canadian 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Outlook
Healthcare in Japan
Strategic Corporate Developments
B.Market Analytics
Table 36: Japanese Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 37: Japanese Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 38: Japanese 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Outlook
Competitive Scenario
Key Statistics
Table 39: European Radiopharmaceuticals Market (2014): Percentage Share Breakdown of Revenues by Company (includes corresponding Graph/Chart)
Table 40: European Diagnostic Radiopharmaceuticals Market (2014): Percentage Share Breakdown of Value Sales by Imaging Modalities
SPECT and PET (includes corresponding Graph/Chart)
Market Trends
New Applications and Products Augur Good Market Prospects
B.Market Analytics
Table 41: European Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 42: European Historic Review for Radiopharmaceuticals by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 43: European 15-Year Perspective for Radiopharmaceuticals by Geographic Region
Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 44: European Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 45: European Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 46: European 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Outlook
B.Market Analytics
Table 47: French Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48: French Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49: French 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Outlook
B.Market Analytics
Table 50: German Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 51: German Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 52: German 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 53: Italian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 54: Italian Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 55: Italian 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Outlook
Strategic Corporate Development
Select Players
B.Market Analytics
Table 56: UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 57: UK Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 58: UK 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 59: Spanish Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 60: Spanish Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 61: Spanish 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
A.Market Analysis
Outlook
B.Market Analytics
Table 62: Russian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 63: Russian Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 64: Russian 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Outlook
Market Overview
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 65: Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 66: Rest of Europe Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 67: Rest of Europe 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Outlook
B.Market Analytics
Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 69: Asia-Pacific Historic Review for Radiopharmaceuticals by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 70: Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Geographic Region
Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 71: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 72: Asia-Pacific Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 73: Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Outlook
Medical Imaging Device Market
An Overview
B.Market Analytics
Table 74: Chinese Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 75: Chinese Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 76: Chinese 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5b. INDIA
A.Market Analysis
Outlook
Product Launch
Jubilant Pharma
A Key Player
B.Market Analytics
Table 77: Indian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 78: Indian Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 79: Indian 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Outlook
Strategic Corporate Development
Singapore Radiopharmaceuticals Pte Ltd.
A Key Player
B.Market Analytics
Table 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 81: Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 82: Rest of Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST
A.Market Analysis
Outlook
B.Market Analytics
Table 83: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 84: Middle East Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 85: Middle East 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA
A.Market Analysis
Outlook
B.Market Analytics
Table 86: Latin American Recent Past, Current & Future Analysis for Radiopharmaceuticals by Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 87: Latin American Historic Review for Radiopharmaceuticals by Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 88: Latin American 15-Year Perspective for Radiopharmaceuticals by Region
Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 89: Latin American Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 90: Latin American Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 91: Latin American 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
7a. BRAZIL
A.Market Analysis
Outlook
B.Market Analytics
Table 92: Brazilian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 93: Brazilian Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 94: Brazilian 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
7b. REST OF LATIN AMERICA
A.Market Analysis
Outlook
B.Market Analytics
Table 95: Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 96: Rest of Latin America Historic Review for Radiopharmaceuticals by Segment
Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 97: Rest of Latin America 15-Year Perspective for Radiopharmaceuticals by Segment
Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 57 (including Divisions/Subsidiaries 64)

The United States (28)
Canada (2)
Japan (1)
Europe (22)
- France (2)
- Germany (3)
- The United Kingdom (3)
- Italy (2)
- Spain (1)
- Rest of Europe (11)
Asia-Pacific (Excluding Japan) (9)
Latin America (1)
Africa (1)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S